Susquehanna International Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281M Sell
797,600
-416,400
-34% -$148M 0.03% 408
2025
Q4
$397M Sell
1,214,000
-146,100
-11% -$46.3M 0.05% 313
2025
Q3
$384M Sell
1,360,100
-721,800
-35% -$209M 0.04% 332
2025
Q2
$581M Buy
2,081,900
+928,500
+81% +$263M 0.08% 187
2025
Q1
$359M Sell
1,153,400
-92,500
-7% -$27.3M 0.06% 244
2024
Q4
$325M Sell
1,245,900
-116,300
-9% -$34.5M 0.05% 294
2024
Q3
$439M Sell
1,362,200
-48,600
-3% -$15.9M 0.08% 220
2024
Q2
$441M Buy
1,410,800
+303,300
+27% +$89.1M 0.08% 185
2024
Q1
$315M Sell
1,107,500
-147,900
-12% -$43.3M 0.05% 278
2023
Q4
$362M Buy
1,255,400
+30,800
+3% +$8.39M 0.07% 233
2023
Q3
$329M Buy
1,224,600
+241,500
+25% +$60.3M 0.07% 223
2023
Q2
$218M Buy
983,100
+184,900
+23% +$42.9M 0.04% 318
2023
Q1
$193M Buy
798,200
+55,400
+7% +$13.6M 0.04% 361
2022
Q4
$195M Sell
742,800
-217,300
-23% -$58.2M 0.05% 335
2022
Q3
$216M Sell
960,100
-131,600
-12% -$31.9M 0.06% 277
2022
Q2
$266M Sell
1,091,700
-264,400
-19% -$64.8M 0.07% 232
2022
Q1
$328M Buy
1,356,100
+374,700
+38% +$86.1M 0.06% 259
2021
Q4
$221M Sell
981,400
-108,600
-10% -$22.9M 0.03% 428
2021
Q3
$232M Sell
1,090,000
-148,900
-12% -$34.3M 0.03% 453
2021
Q2
$302M Buy
1,238,900
+435,900
+54% +$107M 0.04% 357
2021
Q1
$200M Sell
803,000
-406,100
-34% -$96.9M 0.03% 445
2020
Q4
$278M Buy
1,209,100
+293,500
+32% +$67.7M 0.05% 322
2020
Q3
$233M Sell
915,600
-47,800
-5% -$11.8M 0.04% 303
2020
Q2
$227M Sell
963,400
-644,000
-40% -$147M 0.05% 273
2020
Q1
$326M Buy
1,607,400
+292,300
+22% +$63.8M 0.1% 157
2019
Q4
$317M Sell
1,315,100
-63,700
-5% -$14M 0.09% 178
2019
Q3
$267M Sell
1,378,800
-621,300
-31% -$119M 0.09% 186
2019
Q2
$369M Sell
2,000,100
-164,700
-8% -$29.5M 0.13% 118
2019
Q1
$411M Buy
2,164,800
+725,500
+50% +$139M 0.17% 87
2018
Q4
$280M Sell
1,439,300
-55,600
-4% -$10.8M 0.11% 153
2018
Q3
$310M Buy
1,494,900
+39,100
+3% +$7.71M 0.1% 157
2018
Q2
$269M Sell
1,455,800
-382,700
-21% -$67.7M 0.09% 181
2018
Q1
$313M Buy
1,838,500
+128,500
+8% +$23.6M 0.11% 138
2017
Q4
$297M Buy
1,710,000
+55,600
+3% +$9.84M 0.1% 158
2017
Q3
$308M Sell
1,654,400
-152,600
-8% -$27M 0.12% 137
2017
Q2
$311M Sell
1,807,000
-333,000
-16% -$54.2M 0.14% 115
2017
Q1
$351M Buy
2,140,000
+417,400
+24% +$69.4M 0.18% 92
2016
Q4
$252M Buy
1,722,600
+576,700
+50% +$86.8M 0.13% 130
2016
Q3
$191M Buy
1,145,900
+111,800
+11% +$18.9M 0.09% 171
2016
Q2
$157M Sell
1,034,100
-361,000
-26% -$56.1M 0.08% 203
2016
Q1
$209M Buy
1,395,100
+137,100
+11% +$20.4M 0.11% 134
2015
Q4
$204M Sell
1,258,000
-944,500
-43% -$148M 0.09% 181
2015
Q3
$305M Buy
2,202,500
+909,600
+70% +$143M 0.13% 127
2015
Q2
$198M Sell
1,292,900
-43,900
-3% -$7.03M 0.08% 194
2015
Q1
$214M Sell
1,336,800
-961,400
-42% -$151M 0.1% 180
2014
Q4
$366M Buy
2,298,200
+470,000
+26% +$73.2M 0.15% 122
2014
Q3
$257M Buy
1,828,200
+371,800
+26% +$48.5M 0.1% 165
2014
Q2
$172M Sell
1,456,400
-57,900
-4% -$6.7M 0.07% 224
2014
Q1
$187M Sell
1,514,300
-237,300
-14% -$28.8M 0.09% 194
2013
Q4
$200M Buy
1,751,600
+153,700
+10% +$17.5M 0.09% 162
2013
Q3
$179M Buy
1,597,900
+145,900
+10% +$15.8M 0.09% 162
2013
Q2
$143M Buy
+1,452,000
New +$151M 0.08% 186

Other funds holding AMGN

Susquehanna International Group's AMGN Position: Q1 2026 in Review

Susquehanna International Group reduced its Amgen (AMGN) stake by 40% in Q1 2026, selling an estimated $75.3M and leaving 317,913 shares worth $112M. The position accounts for 0.01% of the portfolio, ranked #763.

Susquehanna International Group first reported a position in AMGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $173M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Susquehanna International Group held 317,913 shares of Amgen worth $112M as of Q1 2026.
  • Susquehanna International Group sold 211,258 Amgen shares in Q1 2026, an estimated $75.3M.
  • Amgen made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #763 holding.
  • Susquehanna International Group first reported a position in Amgen in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Amgen position peaked at $173M in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.